<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">39416238</PMID><DateRevised><Year>2024</Year><Month>10</Month><Day>18</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Print">1880-4276</ISSN><JournalIssue CitedMedium="Print"><Volume>40</Volume><Issue>5</Issue><PubDate><Year>2024</Year><Month>Oct</Month></PubDate></JournalIssue><Title>Journal of arrhythmia</Title><ISOAbbreviation>J Arrhythm</ISOAbbreviation></Journal><ArticleTitle>Increased interleukin-6 levels are associated with atrioventricular conduction delay in severe COVID-19 patients.</ArticleTitle><Pagination><StartPage>1137</StartPage><EndPage>1148</EndPage><MedlinePgn>1137-1148</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1002/joa3.13114</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="UNASSIGNED">Severely ill patients with coronavirus disease 2019 (COVID-19) show an increased risk of new-onset atrioventricular blocks (AVBs), associated with high rates of short-term mortality. Recent data suggest that the uncontrolled inflammatory activation observed in these patients, specifically interleukin (IL)-6 elevation, may play an important pathogenic role by directly affecting cardiac electrophysiology. The aim of our study was to assess the acute impact of IL-6 changes on electrocardiographic indices of atrioventricular conduction in severe COVID-19.</AbstractText><AbstractText Label="METHODS" NlmCategory="UNASSIGNED">We investigated (1) the behavior of PR-interval and PR-segment in patients with severe COVID-19 during active phase and recovery, and (2) their association with circulating IL-6 levels over time.</AbstractText><AbstractText Label="RESULTS" NlmCategory="UNASSIGNED">During active disease, COVID-19 patients showed a significant increase of PR-interval and PR-segment. Such atrioventricular delay was transient as these parameters rapidly normalized during recovery. PR-indices significantly correlated with circulating IL-6 levels over time. All these changes and correlations persisted also in the absence of laboratory signs of cardiac strain/injury or concomitant treatment with PR-prolonging drugs, repurposed or not.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="UNASSIGNED">Our study provides evidence that in patients with severe COVID-19 and high-grade systemic inflammation, IL-6 elevation is associated with a significant delay of atrioventricular conduction, independent of concomitant confounding factors. While transient, such alterations may enhance the risk of severe AVB and associated short-term mortality. Our data provide further support to current anti-inflammatory strategies for severe COVID-19, including IL-6 antagonists.</AbstractText><CopyrightInformation>© 2024 The Author(s). Journal of Arrhythmia published by John Wiley &amp; Sons Australia, Ltd on behalf of Japanese Heart Rhythm Society.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Accioli</LastName><ForeName>Riccardo</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Medical Sciences, Surgery and Neurosciences University of Siena Siena Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Division of Internal Medicine and Geriatrics, Electroimmununology Unit University Hospital of Siena Siena Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lazzerini</LastName><ForeName>Pietro Enea</ForeName><Initials>PE</Initials><Identifier Source="ORCID">0000-0001-6721-1214</Identifier><AffiliationInfo><Affiliation>Department of Medical Sciences, Surgery and Neurosciences University of Siena Siena Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Division of Internal Medicine and Geriatrics, Electroimmununology Unit University Hospital of Siena Siena Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Salvini</LastName><ForeName>Viola</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Department of Medical Sciences, Surgery and Neurosciences University of Siena Siena Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Division of Internal Medicine and Geriatrics, Electroimmununology Unit University Hospital of Siena Siena Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cartocci</LastName><ForeName>Alessandra</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Medical Biotechnologies University of Siena Siena Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Verrengia</LastName><ForeName>Decoroso</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Department of Medical Sciences, Surgery and Neurosciences University of Siena Siena Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Division of Internal Medicine and Geriatrics, Electroimmununology Unit University Hospital of Siena Siena Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Marzotti</LastName><ForeName>Tommaso</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of Medical Sciences, Surgery and Neurosciences University of Siena Siena Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Division of Internal Medicine and Geriatrics, Electroimmununology Unit University Hospital of Siena Siena Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Salvadori</LastName><ForeName>Fabio</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Department of Medical Sciences, Surgery and Neurosciences University of Siena Siena Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Division of Internal Medicine and Geriatrics, Electroimmununology Unit University Hospital of Siena Siena Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bisogno</LastName><ForeName>Stefania</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Medical Sciences, Surgery and Neurosciences University of Siena Siena Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Division of Internal Medicine and Geriatrics, Electroimmununology Unit University Hospital of Siena Siena Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cevenini</LastName><ForeName>Gabriele</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Department of Medical Biotechnologies University of Siena Siena Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Voglino</LastName><ForeName>Michele</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Medical Sciences, Surgery and Neurosciences University of Siena Siena Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Division of Internal Medicine and Geriatrics, Electroimmununology Unit University Hospital of Siena Siena Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gallo</LastName><ForeName>Severino</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Medical Sciences, Surgery and Neurosciences University of Siena Siena Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Division of Internal Medicine and Geriatrics, Electroimmununology Unit University Hospital of Siena Siena Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pacini</LastName><ForeName>Sabrina</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Medical Sciences, Surgery and Neurosciences University of Siena Siena Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Division of Internal Medicine and Geriatrics, Electroimmununology Unit University Hospital of Siena Siena Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pazzaglia</LastName><ForeName>Martina</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Medical Sciences, Surgery and Neurosciences University of Siena Siena Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Division of Internal Medicine and Geriatrics, Electroimmununology Unit University Hospital of Siena Siena Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tansini</LastName><ForeName>Angelica</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Medical Sciences, Surgery and Neurosciences University of Siena Siena Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Division of Internal Medicine and Geriatrics, Electroimmununology Unit University Hospital of Siena Siena Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Otranto</LastName><ForeName>Ambra</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Medical Sciences, Surgery and Neurosciences University of Siena Siena Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Division of Internal Medicine and Geriatrics, Electroimmununology Unit University Hospital of Siena Siena Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Laghi-Pasini</LastName><ForeName>Franco</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Department of Medical Sciences, Surgery and Neurosciences University of Siena Siena Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Division of Internal Medicine and Geriatrics, Electroimmununology Unit University Hospital of Siena Siena Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Acampa</LastName><ForeName>Maurizio</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0003-4149-1785</Identifier><AffiliationInfo><Affiliation>Stroke Unit University Hospital of Siena Siena Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Boutjdir</LastName><ForeName>Mohamed</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>VA New York Harbor Healthcare System SUNY Downstate Health Sciences University New York New York USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>NYU Grossman School of Medicine New York New York USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Capecchi</LastName><ForeName>Pier Leopoldo</ForeName><Initials>PL</Initials><AffiliationInfo><Affiliation>Department of Medical Sciences, Surgery and Neurosciences University of Siena Siena Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Division of Internal Medicine and Geriatrics, Electroimmununology Unit University Hospital of Siena Siena Italy.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>07</Month><Day>31</Day></ArticleDate></Article><MedlineJournalInfo><Country>Japan</Country><MedlineTA>J Arrhythm</MedlineTA><NlmUniqueID>101263026</NlmUniqueID><ISSNLinking>1880-4276</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID‐19</Keyword><Keyword MajorTopicYN="N">PR‐interval</Keyword><Keyword MajorTopicYN="N">PR‐segment</Keyword><Keyword MajorTopicYN="N">atrioventricular block</Keyword><Keyword MajorTopicYN="N">interleukin‐6</Keyword></KeywordList><CoiStatement>Dr. Pietro Enea Lazzerini received a grant from Roche Italia S.p.A. outside the submitted work, in 2018. The other authors declare no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>4</Month><Day>18</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2024</Year><Month>6</Month><Day>12</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>7</Month><Day>2</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>10</Month><Day>17</Day><Hour>10</Hour><Minute>6</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>10</Month><Day>17</Day><Hour>10</Hour><Minute>5</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>10</Month><Day>17</Day><Hour>4</Hour><Minute>52</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>7</Month><Day>31</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39416238</ArticleId><ArticleId IdType="pmc">PMC11474750</ArticleId><ArticleId IdType="doi">10.1002/joa3.13114</ArticleId><ArticleId IdType="pii">JOA313114</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Chung MK, Zidar DA, Bristow MR, Cameron SJ, Chan T, Harding CV III, et al. COVID‐19 and cardiovascular disease: from bench to bedside. Circ Res. 2021;128:1214–1236.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8048382</ArticleId><ArticleId IdType="pubmed">33856918</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao YH, Zhao L, Yang XC, Wang P. Cardiovascular complications of SARS‐CoV‐2 infection (COVID‐19): a systematic review and meta‐analysis. Rev Cardiovasc Med. 2021;22:159–165.</Citation><ArticleIdList><ArticleId IdType="pubmed">33792257</ArticleId></ArticleIdList></Reference><Reference><Citation>Coromilas EJ, Kochav S, Goldenthal I, Biviano A, Garan H, Goldbarg S, et al. Worldwide survey of COVID‐19‐associated arrhythmias. Circ Arrhythm Electrophysiol. 2021;14:e009458.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7982128</ArticleId><ArticleId IdType="pubmed">33554620</ArticleId></ArticleIdList></Reference><Reference><Citation>Garcia‐Zamora S, Lee S, Haseeb S, Bazoukis G, Tse G, Alvarez‐Garcia J, et al. Arrhythmias and electrocardiographic findings in coronavirus disease 2019: a systematic review and meta‐analysis. Pacing Clin Electrophysiol. 2021;44:1062–1074.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8250376</ArticleId><ArticleId IdType="pubmed">33890684</ArticleId></ArticleIdList></Reference><Reference><Citation>Liao S‐C, Shao S‐C, Cheng C‐W, Chen Y‐C, Hung M‐J. Incidence rate and clinical impacts of arrhythmia following COVID‐19: a systematic review and meta‐analysis of 17,435 patients. Crit Care. 2020;24:690.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7727094</ArticleId><ArticleId IdType="pubmed">33302973</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen Q, Xu L, Dai Y, Ling Y, Mao J, Qian J, et al. Cardiovascular manifestations in severe and critical patients with COVID‐19. Clin Cardiol. 2020;43:796–802.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7323347</ArticleId><ArticleId IdType="pubmed">32562427</ArticleId></ArticleIdList></Reference><Reference><Citation>Lao N, Lim J, Bashir H, Mahalwar G, Adebolu O, Mangira C, et al. Incidence of atrioventricular blocks and its association with in‐hospital mortality and morbidity in patients with coronavirus disease 2019. J Cardiol. 2022;79:482–488.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8557989</ArticleId><ArticleId IdType="pubmed">34848117</ArticleId></ArticleIdList></Reference><Reference><Citation>Chinitz JS, Goyal R, Harding M, Veseli G, Gruberg L, Jadonath R, et al. Bradyarrhythmias in patients with COVID‐19: marker of poor prognosis? Pacing Clin Electrophysiol. 2020;43:1199–1204.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7461386</ArticleId><ArticleId IdType="pubmed">32820823</ArticleId></ArticleIdList></Reference><Reference><Citation>Pavri BB, Kloo J, Farzad D, Riley JM. Behavior of the PR interval with increasing heart rate in patients with COVID‐19. Heart Rhythm. 2020;17:1434–1438.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7289083</ArticleId><ArticleId IdType="pubmed">32535142</ArticleId></ArticleIdList></Reference><Reference><Citation>Dherange P, Lang J, Qian P, Oberfeld B, Sauer WH, Koplan B, et al. Arrhythmias and COVID‐19: a review. JACC Clin Electrophysiol. 2020;6:1193–1204.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7417167</ArticleId><ArticleId IdType="pubmed">32972561</ArticleId></ArticleIdList></Reference><Reference><Citation>Turagam MK, Musikantow D, Goldman ME, Bassily‐Marcus A, Chu E, Shivamurthy P, et al. Malignant arrhythmias in patients with COVID‐19: incidence, mechanisms, and outcomes. Circ Arrhythm Electrophysiol. 2020;13:e008920.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7668347</ArticleId><ArticleId IdType="pubmed">33026892</ArticleId></ArticleIdList></Reference><Reference><Citation>Selvaraj V, Bavishi C, Patel S, Dapaah‐Afriyie K. Complete heart block associated with Remdesivir in COVID‐19: a case report. Eur Heart J Case Rep. 2021;5:ytab200.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8247739</ArticleId><ArticleId IdType="pubmed">34222786</ArticleId></ArticleIdList></Reference><Reference><Citation>Al‐Jammali S, Al‐Zakhari R, Sheets N, Mahtani A, Stefanishina V, Isber N. Bradyarrhythmia after Remdesivir administration in SARS‐CoV‐2: a review of literature and meta‐analysis of observational studies in epidemiology. Cardiol Res. 2022;13:135–143.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9239507</ArticleId><ArticleId IdType="pubmed">35836734</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhu X, Wang Y, Xiao Y, Gao Q, Gao L, Zhang W, et al. Arrhythmogenic mechanisms of interleukin‐6 combination with hydroxychloroquine and azithromycin in inflammatory diseases. Sci Rep. 2022;12:1075.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8776801</ArticleId><ArticleId IdType="pubmed">35058480</ArticleId></ArticleIdList></Reference><Reference><Citation>Ridjab DA, Ivan I, Budiman F, Juliawati DJ. Current evidence for the risk of PR prolongation, QRS widening, QT prolongation, from lopinavir, ritonavir, atazanavir, and saquinavir: a systematic review. Medicine (Baltimore). 2021;100:e26787.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8341216</ArticleId><ArticleId IdType="pubmed">34397829</ArticleId></ArticleIdList></Reference><Reference><Citation>Kochav SM, Coromilas E, Nalbandian A, Ranard LS, Gupta A, Chung MK, et al. Cardiac arrhythmias in COVID‐19 infection. Circ Arrhythm Electrophysiol. 2020;13:e008719.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7299099</ArticleId><ArticleId IdType="pubmed">32434385</ArticleId></ArticleIdList></Reference><Reference><Citation>Gupta MD, Qamar A, Mp G, Safal S, Batra V, Basia D, et al. Bradyarrhythmias in patients with COVID‐19: a case series. Indian Pacing Electrophysiol J. 2020;20:211–212.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7434619</ArticleId><ArticleId IdType="pubmed">32822746</ArticleId></ArticleIdList></Reference><Reference><Citation>Moey MYY, Sengodan PM, Shah N, McCallen JD, Eboh O, Nekkanti R, et al. Electrocardiographic changes and arrhythmias in hospitalized patients with COVID‐19. Circ Arrhythm Electrophysiol. 2020;13:e009023.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7566299</ArticleId><ArticleId IdType="pubmed">32931707</ArticleId></ArticleIdList></Reference><Reference><Citation>Dagher L, Wanna B, Mikdadi G, Young M, Sohns C, Marrouche NF. High‐degree atrioventricular block in COVID‐19 hospitalized patients. Europace. 2021;23:451–455.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7928988</ArticleId><ArticleId IdType="pubmed">33432349</ArticleId></ArticleIdList></Reference><Reference><Citation>Cheng S, Keyes MJ, Larson MG, McCabe E, Newton‐Cheh C, Levy D, et al. Long‐term outcomes in individuals with prolonged PR interval or first‐degree atrioventricular block. JAMA. 2009;301:2571–2577.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2765917</ArticleId><ArticleId IdType="pubmed">19549974</ArticleId></ArticleIdList></Reference><Reference><Citation>Crisel RK, Farzaneh‐Far R, Na B, Whooley MA. First‐degree atrioventricular block is associated with heart failure and death in persons with stable coronary artery disease: data from the heart and soul study. Eur Heart J. 2011;32:1875–1880.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3202329</ArticleId><ArticleId IdType="pubmed">21606074</ArticleId></ArticleIdList></Reference><Reference><Citation>Kwok CS, Rashid M, Beynon R, Barker D, Patwala A, Morley‐Davies A, et al. Prolonged PR interval, first‐degree heart block and adverse cardiovascular outcomes: a systematic review and meta‐analysis. Heart. 2016;102:672–680.</Citation><ArticleIdList><ArticleId IdType="pubmed">26879241</ArticleId></ArticleIdList></Reference><Reference><Citation>Rasmussen PV, Nielsen JB, Skov MW, Pietersen A, Graff C, Lind B, et al. Electrocardiographic PR interval duration and cardiovascular risk: results from the Copenhagen ECG study. Can J Cardiol. 2017;33:674–681.</Citation><ArticleIdList><ArticleId IdType="pubmed">28449838</ArticleId></ArticleIdList></Reference><Reference><Citation>Dobrzynski H, Anderson RH, Atkinson A, Borbas Z, D'Souza A, Fraser JF, et al. Structure, function and clinical relevance of the cardiac conduction system, including the atrioventricular ring and outflow tract tissues. Pharmacol Ther. 2013;139:260–288.</Citation><ArticleIdList><ArticleId IdType="pubmed">23612425</ArticleId></ArticleIdList></Reference><Reference><Citation>Hulsmans M, Clauss S, Xiao L, Aguirre AD, King KR, Hanley A, et al. Macrophages facilitate electrical conduction in the heart. Cell. 2017;169:510–522.e20.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5474950</ArticleId><ArticleId IdType="pubmed">28431249</ArticleId></ArticleIdList></Reference><Reference><Citation>Lazzerini PE, Capecchi PL, Laghi‐Pasini F. Systemic inflammation and arrhythmic risk: lessons from rheumatoid arthritis. Eur Heart J. 2017;38:1717–1727.</Citation><ArticleIdList><ArticleId IdType="pubmed">27252448</ArticleId></ArticleIdList></Reference><Reference><Citation>Lazzerini PE, Capecchi PL, El‐Sherif N, Laghi‐Pasini F, Boutjdir M. Emerging arrhythmic risk of autoimmune and inflammatory cardiac Channelopathies. J Am Heart Assoc. 2018;7:e010595.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6404431</ArticleId><ArticleId IdType="pubmed">30571503</ArticleId></ArticleIdList></Reference><Reference><Citation>Lazzerini PE, Abbate A, Boutjdir M, Capecchi PL. Fir(e)ing the rhythm: inflammatory cytokines and cardiac arrhythmias. JACC Basic Transl Sci. 2023;8:728–750.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10322731</ArticleId><ArticleId IdType="pubmed">37426535</ArticleId></ArticleIdList></Reference><Reference><Citation>Lazzerini PE, Acampa M, Cupelli M, Gamberucci A, Srivastava U, Nanni C, et al. Unravelling atrioventricular block risk in inflammatory diseases: systemic inflammation acutely delays atrioventricular conduction via a cytokine‐mediated inhibition of Connexin43 expression. J Am Heart Assoc. 2021;10:e022095.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8751850</ArticleId><ArticleId IdType="pubmed">34713715</ArticleId></ArticleIdList></Reference><Reference><Citation>Ergle K, Gooden JY, Ahmed MM. High‐grade atrioventricular block associated with acute influenza. Tex Heart Inst J. 2020;47:220–223.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7529078</ArticleId><ArticleId IdType="pubmed">32997780</ArticleId></ArticleIdList></Reference><Reference><Citation>Akam‐Venkata J, Aggarwal S, Karpawich PP. Influenza associated with circulatory collapse and atrioventricular block in an unvaccinated child with repaired CHD. Cardiol Young. 2020;30:740–742.</Citation><ArticleIdList><ArticleId IdType="pubmed">32308173</ArticleId></ArticleIdList></Reference><Reference><Citation>Cheng WL, Lin CS. Transient atrioventricular block as a complication of influenza a virus: a case report. J Acute Med. 2021;11:102–104.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8440439</ArticleId><ArticleId IdType="pubmed">34595094</ArticleId></ArticleIdList></Reference><Reference><Citation>Badheeb M, Zarich S, Fara FI, Alam MM. Permanent complete heart block: a rare complication of influenza infection. Cureus. 2023;15:e51166.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10813590</ArticleId><ArticleId IdType="pubmed">38283436</ArticleId></ArticleIdList></Reference><Reference><Citation>Rivera‐Guzmán N, Del Olmo‐Arroyo F, Robles‐Arías CM, Rodríguez‐Cintrón W. Transient AV block as a hemodynamic complication of the influenza a virus: a case report. P R Health Sci J. 2016;35:173–175.</Citation><ArticleIdList><ArticleId IdType="pubmed">27623145</ArticleId></ArticleIdList></Reference><Reference><Citation>Beinart R, Morganti K, Ruskin J, Mela T. H1N1 influenza a virus induced atrioventricular block. J Cardiovasc Electrophysiol. 2011;22:711–713.</Citation><ArticleIdList><ArticleId IdType="pubmed">20958837</ArticleId></ArticleIdList></Reference><Reference><Citation>Lazzerini PE, Boutjdir M, Capecchi PL. COVID‐19, arrhythmic risk, and inflammation: mind the gap! Circulation. 2020;142:7–9.</Citation><ArticleIdList><ArticleId IdType="pubmed">32286863</ArticleId></ArticleIdList></Reference><Reference><Citation>Lazzerini PE, Laghi‐Pasini F, Boutjdir M, Capecchi PL. Inflammatory cytokines and cardiac arrhythmias: the lesson from COVID‐19. Nat Rev Immunol. 2022;22:270–272.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8959266</ArticleId><ArticleId IdType="pubmed">35347295</ArticleId></ArticleIdList></Reference><Reference><Citation>Lazzerini PE, Accioli R, Acampa M, Zhang WH, Verrengia D, Cartocci A, et al. Interleukin‐6 elevation is a key pathogenic factor underlying COVID‐19‐associated heart rate‐corrected QT interval prolongation. Front Cardiovasc Med. 2022;9:893681.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9161021</ArticleId><ArticleId IdType="pubmed">35665254</ArticleId></ArticleIdList></Reference><Reference><Citation>Yüce M, Filiztekin E, Özkaya KG. COVID‐19 diagnosis ‐a review of current methods. Biosens Bioelectron. 2021;172:112752.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7584564</ArticleId><ArticleId IdType="pubmed">33126180</ArticleId></ArticleIdList></Reference><Reference><Citation>Dhindsa S, Zhang N, McPhaul MJ, Wu Z, Ghoshal AK, Erlich EC, et al. Association of circulating sex hormones with inflammation and disease severity in patients with COVID‐19. JAMA Netw Open. 2021;4:e2111398.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8150664</ArticleId><ArticleId IdType="pubmed">34032853</ArticleId></ArticleIdList></Reference><Reference><Citation>Soliman EZ, Rautaharju PM. Heart rate adjustment of PR interval in middle‐aged and older adults. J Electrocardiol. 2012;45:66–69.</Citation><ArticleIdList><ArticleId IdType="pubmed">21784432</ArticleId></ArticleIdList></Reference><Reference><Citation>Kusumoto FM, Schoenfeld MH, Barrett C, Edgerton JR, Ellenbogen KA, Gold MR, et al. 2018 ACC/AHA/HRS guideline on the evaluation and Management of Patients with Bradycardia and Cardiac Conduction Delay: executive summary: a report of the American College of Cardiology/American Heart Association task force on clinical practice guidelines, and the Heart Rhythm Society. Circulation. 2019;140:e333–e381.</Citation><ArticleIdList><ArticleId IdType="pubmed">30586771</ArticleId></ArticleIdList></Reference><Reference><Citation>van der Ende MY, Siland JE, Snieder H, van der Harst P, Rienstra M. Population‐based values and abnormalities of the electrocardiogram in the general Dutch population: the LifeLines cohort study. Clin Cardiol. 2017;40:865–872.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6490340</ArticleId><ArticleId IdType="pubmed">28605034</ArticleId></ArticleIdList></Reference><Reference><Citation>Dilaveris PE, Färbom P, Batchvarov V, Ghuran A, Malik M. Circadian behavior of P‐wave duration, P‐wave area, and PR interval in healthy subjects. Ann Noninvasive Electrocardiol. 2001;6:92–97.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7027634</ArticleId><ArticleId IdType="pubmed">11333165</ArticleId></ArticleIdList></Reference><Reference><Citation>Tracey KJ. The inflammatory reflex. Nature. 2002;420:853–859.</Citation><ArticleIdList><ArticleId IdType="pubmed">12490958</ArticleId></ArticleIdList></Reference><Reference><Citation>Lazzerini PE, Acampa M, Hammoud M, Maffei S, Capecchi PL, Selvi E, et al. Arrhythmic risk during acute infusion of infliximab: a prospective, single‐blind, placebo‐controlled, crossover study in patients with chronic arthritis. J Rheumatol. 2008;35:1958–1965.</Citation><ArticleIdList><ArticleId IdType="pubmed">18709695</ArticleId></ArticleIdList></Reference><Reference><Citation>Lazzerini PE, Laghi‐Pasini F, Acampa M, Srivastava U, Bertolozzi I, Giabbani B, et al. Systemic inflammation rapidly induces reversible atrial electrical remodeling: the role of Interleukin‐6–mediated changes in Connexin expression. J Am Heart Assoc. 2019;8:e011006.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6759884</ArticleId><ArticleId IdType="pubmed">31423933</ArticleId></ArticleIdList></Reference><Reference><Citation>Frangogiannis NG. Cardiac fibrosis. Cardiovasc Res. 2021;117:1450–1488.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8152700</ArticleId><ArticleId IdType="pubmed">33135058</ArticleId></ArticleIdList></Reference><Reference><Citation>Nguyen MN, Kiriazis H, Gao XM, Du XJ. Cardiac fibrosis and Arrhythmogenesis. Compr Physiol. 2017;7:1009–1049.</Citation><ArticleIdList><ArticleId IdType="pubmed">28640451</ArticleId></ArticleIdList></Reference><Reference><Citation>Nikolaidou T, Cai XJ, Stephenson RS, Yanni J, Lowe T, Atkinson AJ, et al. Congestive heart failure leads to prolongation of the PR interval and atrioventricular junction enlargement and Ion Channel Remodelling in the rabbit. PLoS One. 2015;10:e0141452.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4624927</ArticleId><ArticleId IdType="pubmed">26509807</ArticleId></ArticleIdList></Reference><Reference><Citation>Chang Y, Yu T, Yang H, Peng Z. Exhaustive exercise‐induced cardiac conduction system injury and changes of cTnT and Cx43. Int J Sports Med. 2015;36:1–8.</Citation><ArticleIdList><ArticleId IdType="pubmed">25254896</ArticleId></ArticleIdList></Reference><Reference><Citation>Rosenthal N. A Guardian of the heartbeat. N Engl J Med. 2017;377:84–86.</Citation><ArticleIdList><ArticleId IdType="pubmed">28679094</ArticleId></ArticleIdList></Reference><Reference><Citation>Mihara M, Hashizume M, Yoshida H, Suzuki M, Shiina M. IL‐6/IL‐6 receptor system and its role in physiological and pathological conditions. Clin Sci (Lond). 2012;122:143–159.</Citation><ArticleIdList><ArticleId IdType="pubmed">22029668</ArticleId></ArticleIdList></Reference><Reference><Citation>Grant AO. Cardiac ion channels. Circ Arrhythm Electrophysiol. 2009;2:185–194.</Citation><ArticleIdList><ArticleId IdType="pubmed">19808464</ArticleId></ArticleIdList></Reference><Reference><Citation>Lazzerini PE, Laghi‐Pasini F, Acampa M, Boutjdir M, Leopoldo CP. IL‐6 (interleukin 6) blockade and heart rate corrected QT interval prolongation in COVID‐19. Circ Arrhythm Electrophysiol. 2020;13:e008791.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7482616</ArticleId><ArticleId IdType="pubmed">32702997</ArticleId></ArticleIdList></Reference><Reference><Citation>Carmona CA, Levent F, Lee K, Trivedi B. Atrioventricular conduction abnormalities in multisystem inflammatory syndrome in children. Case Rep Pediatr. 2021;2021:6124898.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8486562</ArticleId><ArticleId IdType="pubmed">34603810</ArticleId></ArticleIdList></Reference><Reference><Citation>Pulakurthi YS, Pederson JM, Saravu K, Gupta N, Balasubramanian P, Kamrowski S, et al. Corticosteroid therapy for COVID‐19: a systematic review and meta‐analysis of randomized controlled trials. Medicine (Baltimore). 2021;100:e25719.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8137023</ArticleId><ArticleId IdType="pubmed">34011029</ArticleId></ArticleIdList></Reference><Reference><Citation>Shankar‐Hari M, Vale CL, Godolphin PJ, Fisher D, Higgins JPT, Spiga F, et al. Association between administration of IL‐6 antagonists and mortality among patients hospitalized for COVID‐19: a meta‐analysis. JAMA. 2021;326:499–518.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8261689</ArticleId><ArticleId IdType="pubmed">34228774</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>